Skip to content
ChickenStockChickenStock
Research068270
Celltrion logo

Celltrion (068270) stock

KOSPI · Pharmaceuticals

KRW 214,500+0.23%(+500)

As of the Nov 16 regular-session close (Korea)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

31.51x

P/B

2.75x

P/S

10.14x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Consolidated · Filed Aug 14, 2026KRW 1.4 trillionKRW 451.8 billionKRW 371.3 billion+45.0%
Q1 2026Consolidated · Filed May 15, 2026KRW 1.1 trillionKRW 321.9 billionKRW 349.8 billion+36.0%
Q4 2025Consolidated · Filed Mar 16, 2026KRW 1.3 trillionKRW 475.2 billionKRW 527.9 billion—
Q3 2025Consolidated · Filed Nov 14, 2025KRW 1 trillionKRW 301.4 billionKRW 331.9 billion+16.7%
Q2 2025Consolidated · Filed Aug 14, 2025KRW 961.5 billionKRW 242.5 billionKRW 63.3 billion+9.9%
Q1 2025Consolidated · Filed May 15, 2025KRW 841.9 billionKRW 149.4 billionKRW 108.3 billion+14.2%
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 16, 2026KRW 4.2 trillionKRW 1.2 trillionKRW 1 trillion—
FY2024Consolidated · Filed Mar 17, 2025KRW 3.6 trillionKRW 492 billionKRW 418.9 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
4.65%
Of trading value on Nov 13, 2026
Short-sale value
KRW 6.36 billion
Previous 20-day average 4.56%
Net short position
1,153,970 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
7,417,142 shares
As of Nov 13, 2026 · 3.20% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20264.65%KRW 6.36 billion
Nov 12, 20265.08%KRW 7.98 billion
Nov 11, 20261.92%KRW 4.5 billion
Nov 10, 20264.40%KRW 11.61 billion
Nov 9, 20264.32%KRW 8.68 billion
Nov 6, 20266.78%KRW 20.03 billion
Nov 5, 20261.41%KRW 8.48 billion
Nov 4, 20263.26%KRW 9.77 billion
Nov 3, 20267.91%KRW 5.89 billion
Nov 2, 20264.76%KRW 3.9 billion

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

Celltrion (068270) stock information

KOSPI

Celltrion (068270) is listed on KOSPI. Its market capitalization is about KRW 49.7 trillion. On trailing-twelve-month earnings the P/E ratio is 31.51, and the P/B ratio is 2.75. Return on equity is 8.7%. These figures are computed in-house from official filings and are reference information only.

Celltrion — frequently asked questions

What is the P/E ratio of Celltrion (068270)?
On a trailing-twelve-month basis, 068270 trades at a P/E ratio of 31.51. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Celltrion?
068270 has a market capitalization of about KRW 49.7 trillion. The figure moves with the share price and is refreshed each trading day.
Does Celltrion pay a dividend?
068270 has a dividend yield of about 0.35%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.